REFERENCES
1. Banyoi, S.; Porseryd, T.; Larsson, J.; Grahn, M.; Dinnétz, P. The effects of exposure to environmentally relevant PFAS concentrations for aquatic organisms at different consumer trophic levels: systematic review and meta-analyses. Environ. Pollut. 2022, 315, 120422.
2. Wang, Z.; Dewitt, J. C.; Higgins, C. P.; Cousins, I. T. A never-ending story of per- and polyfluoroalkyl substances (PFASs)? Environ. Sci. Technol. 2017, 51, 2508-18.
3. Sunderland, E. M.; Hu, X. C.; Dassuncao, C.; Tokranov, A. K.; Wagner, C. C.; Allen, J. G. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects. J. Expo. Sci. Environ. Epidemiol. 2018, 29, 131-47.
4. Bjerregaard-Olesen, C.; Bossi, R.; Liew, Z.; et al. Maternal serum concentrations of perfluoroalkyl acids in five international birth cohorts. Int. J. Hyg. Environ. Health. 2017, 220, 86-93.
5. Cariou, R.; Veyrand, B.; Yamada, A.; et al. Perfluoroalkyl acid (PFAA) levels and profiles in breast milk, maternal and cord serum of French women and their newborns. Environ. Int. 2015, 84, 71-81.
6. Fei, C.; Mclaughlin, J. K.; Tarone, R. E.; Olsen, J. Perfluorinated chemicals and fetal growth: a study within the Danish national birth cohort. Environ. Health. Perspect. 2007, 115, 1677-82.
7. Ma, D.; Lu, Y.; Liang, Y.; et al. A critical review on transplacental transfer of per- and polyfluoroalkyl substances: prenatal exposure levels, characteristics, and mechanisms. Environ. Sci. Technol. 2021, 56, 6014-26.
8. Rice, D.; Barone, S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health. Perspect. 2000, 108, 511-33.
9. Mshaty, A.; Haijima, A.; Takatsuru, Y.; et al. Neurotoxic effects of lactational exposure to perfluorooctane sulfonate on learning and memory in adult male mouse. Food. Chem. Toxicol. 2020, 145, 111710.
10. Wang, X.; Shi, X.; Zheng, S.; et al. Perfluorooctane sulfonic acid (PFOS) exposures interfere with behaviors and transcription of genes on nervous and muscle system in zebrafish embryos. Sci. Total. Environ. 2022, 848, 157816.
11. Gao, X. X.; Zuo, Q. L.; Fu, X. H.; Song, L. L.; Cen, M. Q.; Wu, J. Association between prenatal exposure to per- and polyfluoroalkyl substances and neurodevelopment in children: evidence based on birth cohort. Environ. Res. 2023, 236, 116812.
12. Itoh, S.; Yamazaki, K.; Suyama, S.; et al. The association between prenatal perfluoroalkyl substance exposure and symptoms of attention-deficit/hyperactivity disorder in 8-year-old children and the mediating role of thyroid hormones in the Hokkaido study. Environ. Int. 2022, 159, 107026.
13. Vuong, A. M.; Webster, G. M.; Yolton, K.; et al. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: the HOME study. Environ. Res. 2021, 195, 110825.
14. Carrizosa, C.; Murcia, M.; Ballesteros, V.; et al. Prenatal perfluoroalkyl substance exposure and neuropsychological development throughout childhood: the INMA Project. J. Hazard. Mater. 2021, 416, 125185.
15. Xie, Z.; Liang, H.; Miao, M.; et al. Prenatal exposure to perfluoroalkyl substances and cognitive and neurobehavioral development in children at 6 years of age. Environ. Sci. Technol. 2023, 57, 8213-24.
16. Zhang, B.; Wang, Z.; Zhang, J.; et al. Prenatal exposure to per- and polyfluoroalkyl substances, fetal thyroid function, and intelligence quotient at 7 years of age: findings from the Sheyang Mini Birth Cohort Study. Environ. Int. 2024, 187, 108720.
17. Li, Q.; Huang, J.; Cai, D.; et al. Prenatal exposure to legacy and alternative per- and polyfluoroalkyl substances and neuropsychological development trajectories over the first 3 years of life. Environ. Sci. Technol. 2023, 57, 3746-57.
18. Zhou, Y.; Li, Q.; Wang, P.; et al. Associations of prenatal PFAS exposure and early childhood neurodevelopment: evidence from the Shanghai Maternal-Child Pairs Cohort. Environ. Int. 2023, 173, 107850.
19. Zhang, B.; Wang, Z.; Zhang, J.; et al. Prenatal perfluoroalkyl substances exposure and neurodevelopment in toddlers: findings from SMBCS. Chemosphere 2023, 313, 137587.
20. Oh, J.; Shin, H.; Nishimura, T.; Rahman, M. S.; Takahashi, N.; Tsuchiya, K. J. Perfluorooctanoate and perfluorooctane sulfonate in umbilical cord blood and child cognitive development: Hamamatsu Birth Cohort for Mothers and Children (HBC Study). Environ. Int. 2022, 163, 107215.
21. National Research Council (US) and Institute of Medicine (US) Committee on Integrating the Science of Early Childhood Development. From neurons to neighborhoods: the science of early childhood development. Washington (DC): National Academies Press; 2000.
22. Brown, T. T.; Jernigan, T. L. Brain development during the preschool years. Neuropsychol. Rev. 2012, 22, 313-33.
23. Choi, J. W.; Parenti, M.; Slupsky, C. M.; Tancredi, D. J.; Schmidt, R. J.; Shin, H. Maternal serum and placental metabolomes in association with prenatal exposure to per- and polyfluoroalkyl substances and their relevance to child neurodevelopment in an ASD-enriched cohort. Environ. Pollut. 2025, 383, 126811.
24. Kiriyama, Y.; Nochi, H. The biosynthesis, signaling, and neurological functions of bile acids. Biomolecules 2019, 9, 232.
25. Wu, Y.; Qiu, Y.; Su, M.; Wang, L.; Gong, Q.; Wei, X. Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain. CNS. Neurosci. Ther. 2023, 29, 1981-98.
26. Ren, Z.; Zhao, L.; Zhao, M.; et al. Increased intestinal bile acid absorption contributes to age-related cognitive impairment. Cell. Rep. Med. 2024, 5, 101543.
27. Guo, Y.; Huang, J.; Xue, J.; et al. Intrauterine exposure to long-chain perfluorocarboxylic acids (PFCAs) were associated with reduced primary bile acids in three-year-old children: findings from a prospective birth cohort study. Environ. Pollut. 2024, 360, 124583.
28. Wu, M.; Cheng, Y.; Zhang, R.; et al. Molecular mechanism and therapeutic strategy of bile acids in Alzheimer’s disease from the emerging perspective of the microbiota–gut–brain axis. Biomed. Pharmacother. 2024, 178, 117228.
29. Zhang, Y.; Li, J.; Li, J.; et al. Cross-sectional and longitudinal associations of circulating bile acids and dementia: a systematic review. GeroScience 2025, 48, 4789-804.
30. Cai, D.; Li, S.; Guo, Y.; et al. Effects of serum insulin and insulin-like growth factor 1 levels on the association between fetal growth and per- and polyfluoroalkyl substance exposure based on a nested case–control study. Environ. Sci. Technol. 2025, 59, 3841-52.
31. Li, J.; Cai, D.; Chu, C.; et al. Transplacental transfer of per- and polyfluoroalkyl substances (PFASs): differences between preterm and full-term deliveries and associations with placental transporter mRNA expression. Environ. Sci. Technol. 2020, 54, 5062-70.
32. Cai, D.; Li, Q.; Chu, C.; et al. High trans-placental transfer of perfluoroalkyl substances alternatives in the matched maternal-cord blood serum: evidence from a birth cohort study. Sci. Total. Environ. 2020, 705, 135885.
33. Hornung, R. W.; Reed, L. D. Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hyg. 1990, 5, 46-51.
34. Sjödin, A.; Wong, L.; Jones, R. S.; et al. Serum concentrations of polybrominated diphenyl ethers (PBDEs) and polybrominated biphenyl (PBB) in the United States population: 2003-2004. Environ. Sci. Technol. 2008, 42, 1377-84.
35. Wang, Y.; Rogan, W. J.; Chen, P.; et al. Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study. Environ. Health. Perspect. 2014, 122, 529-34.
36. Xiao, F. Emerging poly- and perfluoroalkyl substances in the aquatic environment: a review of current literature. Water. Res. 2017, 124, 482-95.
37. Calafat, A. M.; Kato, K.; Hubbard, K.; Jia, T.; Botelho, J. C.; Wong, L. Legacy and alternative per- and polyfluoroalkyl substances in the U.S. general population: paired serum-urine data from the 2013-2014 National Health and Nutrition Examination Survey. Environ. Int. 2019, 131, 105048.
38. Cheng, S.; Zhu, L.; Faden, H. S. Interactions of bile acids and the gut microbiota: learning from the differences in Clostridium difficile infection between children and adults. Physiol. Genomics. 2019, 51, 218-23.
39. Laursen, M. F. Gut microbiota development: influence of diet from infancy to toddlerhood. Ann. Nutr. Metab. 2021, 77, 21-34.
40. Tian, Y.; Rimal, B.; Gui, W.; et al. Early life short-term exposure to polychlorinated biphenyl 126 in mice leads to metabolic dysfunction and microbiota changes in adulthood. Int. J. Mol. Sci. 2022, 23, 8220.
41. Collins, S. L.; Stine, J. G.; Bisanz, J. E.; Okafor, C. D.; Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 2022, 21, 236-47.
42. Wechsler, D. Wechsler Preschool and Primary Scale of Intelligence. Fourth Edition (WPPSI-IV). 2012. https://www.pearsonassessments.com/en-us/store/professional-assessments/cognition-%26-neuro/wechsler-preschool-and-primary-scale-of-intelligence-%7c-fourth-edition/p/100000102?productId=0150012608&tab=faqs. (accessed on 17 Aug 2026).
43. Tong, J.; Liang, C.; Wu, X.; et al. Prenatal serum thallium exposure and cognitive development among preschool-aged children: a prospective cohort study in China. Environ. Pollut. 2022, 293, 118545.
44. Wechsler, D. Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV). APA PsycTests; 2003.
45. Bonham, K. S.; Fahur Bottino, G.; Mccann, S. H.; et al.; The RESONANCE Consortium. Gut-resident microorganisms and their genes are associated with cognition and neuroanatomy in children. Sci. Adv. 2023, 9, eadi0497.
46. Black, M.; Adjei, N. K. Longitudinal analysis of cognitive development across childhood and adolescence: evidence from the UK Millennium Cohort Study. Lancet 2022, 400, S23.
47. Wang, H.; Luo, F.; Zhang, Y.; et al. Prenatal exposure to perfluoroalkyl substances and child intelligence quotient: evidence from the Shanghai birth cohort. Environ. Int. 2023, 174, 107912.
48. Nagin, D. S.; Odgers, C. L. Group-based trajectory modeling in clinical research. Annu. Rev. Clin. Psychol. 2010, 6, 109-38.
49. Wieczorek, M.; Rotonda, C.; Coste, J.; et al. Trajectory analysis combining pain and physical function in individuals with knee and hip osteoarthritis: results from the French KHOALA cohort. Rheumatology 2020, 59, 3488-98.
50. Nagin, D. S.; Jones, B. L.; Passos, V. L.; Tremblay, R. E. Group-based multi-trajectory modeling. Stat. Methods. Med. Res. 2016, 27, 2015-23.
52. Hooda, S.; Mondal, P. Predictive modeling of plastic pyrolysis process for the evaluation of activation energy: explainable artificial intelligence based comprehensive insights. J. Environ. Manage. 2024, 360, 121189.
53. Zhan, L.; Zou, D.; Ma, L.; et al. Meta-analysis of the fate and transformation of heavy metals during pyrolysis process via data-mining the literature and machine learning. J. Anal. Appl. Pyrolysis. 2025, 190, 107169.
54. Cheng, Y.; Gu, K.; Ji, W.; Hu, Z.; Yang, Y.; Zhou, Y. Two-year hypertension incidence risk prediction in populations in the desert regions of Northwest China: prospective cohort study. J. Med. Internet. Res. 2025, 27, e68442.
55. Harris, M. H.; Oken, E.; Rifas-Shiman, S. L.; et al. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition. Environ. Int. 2018, 115, 358-69.
56. Mogensen, U. B.; Grandjean, P.; Nielsen, F.; Weihe, P.; Budtz-Jørgensen, E. Breastfeeding as an exposure pathway for perfluorinated alkylates. Environ. Sci. Technol. 2015, 49, 10466-73.
57. Nohr, E. A.; Frydenberg, M.; Henriksen, T. B.; Olsen, J. Does low participation in cohort studies induce bias? Epidemiology 2006, 17, 413-8.
58. Meng, Q.; Inoue, K.; Ritz, B.; Olsen, J.; Liew, Z. Prenatal exposure to perfluoroalkyl substances and birth outcomes; an updated analysis from the Danish national birth cohort. Int. J. Environ. Res. Public. Health. 2018, 15, 1832.
59. Sagiv, S. K.; Rifas-Shiman, S. L.; Fleisch, A. F.; et al. Early-pregnancy plasma concentrations of perfluoroalkyl substances and birth outcomes in Project Viva: confounded by pregnancy hemodynamics? Am. J. Epidemiol. 2018, 187, 793-802.
60. Hjermitslev, M. H.; Long, M.; Wielsøe, M.; Bonefeld-Jørgensen, E. C. Persistent organic pollutants in Greenlandic pregnant women and indices of foetal growth: the ACCEPT study. Sci. Total. Environ. 2020, 698, 134118.
61. Lau, C.; Anitole, K.; Hodes, C.; Lai, D.; Pfahles-Hutchens, A.; Seed, J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99, 366-94.
62. Niijima, S. Studies on the conjugating activity of bile acids in children. Pediatr. Res. 1985, 19, 302-7.
63. Zöhrer, E.; Resch, B.; Scharnagl, H.; et al. Serum bile acids in term and preterm neonates: a case–control study determining reference values and the influence of early-onset sepsis. Medicine 2016, 95, e5219.
64. Beck, I. H.; Bilenberg, N.; Möller, S.; et al. Association between prenatal and early postnatal exposure to perfluoroalkyl substances and IQ score in 7-year-old children from the Odense child cohort. Am. J. Epidemiol. 2023, 192, 1522-35.
65. Goodman, C. V.; Till, C.; Green, R.; et al. Prenatal exposure to legacy PFAS and neurodevelopment in preschool-aged Canadian children: the MIREC cohort. Neurotoxicol. Teratol. 2023, 98, 107181.
66. Skogheim, T. S.; Villanger, G. D.; Weyde, K. V. F.; et al. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children. Int. J. Hyg. Environ. Health. 2020, 223, 80-92.
67. Spratlen, M. J.; Perera, F. P.; Lederman, S. A.; et al. The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment. Environ. Pollut. 2020, 263, 114444.
68. Vuong, A. M.; Yolton, K.; Xie, C.; et al. Prenatal and childhood exposure to poly- and perfluoroalkyl substances (PFAS) and cognitive development in children at age 8 years. Environ. Res. 2019, 172, 242-8.
69. Ames, J. L.; Sharma, V.; Lyall, K. Effects of early-life PFAS exposure on child neurodevelopment: a review of the evidence and research gaps. Curr. Envir. Health. Rep. 2025, 12, 9.
70. Currie, S. D.; Benson, D. B.; Xie, Z.; Wang, J.; Tang, L. Utilization of artificial intelligence coupled with a high-throughput, high-content platform in the exploration of neurodevelopmental toxicity of individual and combined PFAS. J. Xenobiot. 2025, 15, 24.
71. Oh, J.; Schmidt, R. J.; Tancredi, D.; et al. Prenatal exposure to per- and polyfluoroalkyl substances and cognitive development in infancy and toddlerhood. Environ. Res. 2021, 196, 110939.
72. Dayimu, A.; Qian, W.; Fan, B.; et al. Trajectories of haemoglobin and incident stroke risk: a longitudinal cohort study. BMC. Public. Health. 2019, 19, 1395.
73. Gao, Y.; Luo, J.; Zhang, Y.; et al.; for the Shanghai Birth Cohort. Prenatal exposure to per- and polyfluoroalkyl substances and child growth trajectories in the first two years. Environ. Health. Perspect. 2022, 130, 037006.
74. Hackman, D. A.; Farah, M. J. Socioeconomic status and the developing brain. Trends. Cogn. Sci. 2009, 13, 65-73.
75. Grandjean, P.; Landrigan, P. J. Neurobehavioural effects of developmental toxicity. Lancet. Neurol. 2014, 13, 330-8.
76. Shaw, P.; Greenstein, D.; Lerch, J.; et al. Intellectual ability and cortical development in children and adolescents. Nature 2006, 440, 676-9.
77. Campbell, F. A.; Ramey, C. T.; Pungello, E.; Sparling, J.; Miller-Johnson, S. Early childhood education: young adult outcomes from the Abecedarian Project. Appl. Dev. Sci. 2010, 6, 42-57.
78. Mahapatra, A.; Gupta, P.; Suman, A.; Ray, S. S.; Malafaia, G.; Singh, R. K. Unraveling the mechanisms of perfluorooctanesulfonic acid-induced dopaminergic neurotoxicity and microglial activation in developing zebrafish. Sci. Total. Environ. 2023, 887, 164030.
79. Li, Z.; Liu, Q.; Liu, C.; et al. Evaluation of PFOS-mediated neurotoxicity in rat primary neurons and astrocytes cultured separately or in co-culture. Toxicol. In. Vitro. 2017, 38, 77-90.
80. Wu, K.; Tang, A.; Zhang, X.; et al. Relationship between PFAS and attention-deficit/hyperactivity disorder or autism spectrum disorder: epidemiological and experimental evidence. Ecotoxicol. Environ. Saf. 2025, 302, 118519.
81. Xu, Y.; Fletcher, T.; Pineda, D.; et al. Serum half-lives for short- and long-chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam. Environ. Health. Perspect. 2020, 128, 077004.
82. Oh, J.; Bennett, D. H.; Calafat, A. M.; et al. Prenatal exposure to per- and polyfluoroalkyl substances in association with autism spectrum disorder in the MARBLES study. Environ. Int. 2021, 147, 106328.
83. Fleishman, J. S.; Kumar, S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Sig. Transduct. Target. Ther. 2024, 9, 97.
84. Wahlström, A.; Sayin, S. I.; Marschall, H.; Bäckhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell. Metab. 2016, 24, 41-50.
85. Wang, K.; Zhang, P.; Sun, H.; et al. Dual-function natural products: farnesoid X receptor agonist/inflammation inhibitor for metabolic dysfunction-associated steatotic liver disease therapy. Chin. J. Nat. Med. 2024, 22, 965-76.
86. Ge, X.; Huang, S.; Ren, C.; Zhao, L. Taurocholic acid and glycocholic acid inhibit inflammation and activate farnesoid X receptor expression in LPS-stimulated zebrafish and macrophages. Molecules 2023, 28, 2005.
87. Kiriyama, Y.; Nochi, H. Role of microbiota-modified bile acids in the regulation of intracellular organelles and neurodegenerative diseases. Genes 2023, 14, 825.
88. Pan, X.; Elliott, C. T.; Mcguinness, B.; et al. Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer’s disease. Metabolites 2017, 7, 28.
89. Yu, X.; Zhang, Y.; Cogliati, B.; et al. Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice. Toxicology 2024, 502, 153719.
90. Fragki, S.; Dirven, H.; Fletcher, T.; et al. Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not? Crit. Rev. Toxicol. 2021, 51, 141-64.
91. Sadrabadi, F.; Alarcan, J.; Sprenger, H.; Braeuning, A.; Buhrke, T. Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes. Arch. Toxicol. 2023, 98, 507-24.
92. Guo, C.; Zhang, S.; Zhang, H.; et al. Per- and polyfluoroalkyl substances (PFAS) disrupt gut microbiome composition and metabolism in metabolic syndrome: evidence from a host-free in vitro colonic model. Environ. Pollut. 2025, 386, 127189.
93. Ahrens, A. P.; Hyötyläinen, T.; Petrone, J. R.; et al. Infant microbes and metabolites point to childhood neurodevelopmental disorders. Cell 2024, 187, 1853-73.e15.
94. Omoike, O. E.; Pack, R. P.; Mamudu, H. M.; et al. Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress. Environ. Res. 2021, 196, 110361.
95. Wielsøe, M.; Long, M.; Ghisari, M.; Bonefeld-Jørgensen, E. C. Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro. Chemosphere 2015, 129, 239-45.
96. Staley, C.; Weingarden, A. R.; Khoruts, A.; Sadowsky, M. J. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl. Microbiol. Biotechnol. 2016, 101, 47-64.
97. Compañ-Gabucio, L.; Torres-Collado, L.; García-de-la-Hera, M. Dietary patterns in children with neurodevelopmental disorders. Nutrients 2024, 16, 2460.
98. Esposito, M.; Mirizzi, P.; Fadda, R.; et al. Food selectivity in children with autism: guidelines for assessment and clinical interventions. Int. J. Environ. Res. Public. Health. 2023, 20, 5092.
99. Ridlon, J. M.; Kang, D.; Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid. Res. 2006, 47, 241-59.
101. Hofmann, A. F.; Hagey, L. R. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. J. Lipid. Res. 2014, 55, 1553-95.
102. Braun, J. M.; Gennings, C.; Hauser, R.; Webster, T. F. What can epidemiological studies tell us about the impact of chemical mixtures on human health? Environ. Health. Perspect. 2016, 124, A6-9.
